Advertisement

Topics

Catalent and Valerius Link on Biosimilars

03:20 EDT 17 May 2018 | CHEManager

US drug development specialist Catalent Pharma Solutions and Valerius Biopharma, a Swiss biopharmaceutical company providing interchangeable treatment options for high-priced orphan and non-orphan biologics, have announced plans to collaborate on the development and manufacture of Valerius’ biosimilar products.

Original Article: Catalent and Valerius Link on Biosimilars

NEXT ARTICLE

More From BioPortfolio on "Catalent and Valerius Link on Biosimilars"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...